Wells Fargo’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.5K | Buy |
+6,990
| New | +$11.5K | ﹤0.01% | 5463 |
|
|
2024
Q2 | – | Sell |
-268
| Closed | -$284 | – | 6878 |
|
|
2024
Q1 | $284 | Sell |
268
-996
| -79% | -$1.06K | ﹤0.01% | 6022 |
|
|
2023
Q4 | $1.33K | Buy |
1,264
+52
| +4% | +$55 | ﹤0.01% | 5721 |
|
|
2023
Q3 | $1.36K | Buy |
1,212
+1,058
| +687% | +$1.19K | ﹤0.01% | 5778 |
|
|
2023
Q2 | $232 | Buy |
154
+7
| +5% | +$11 | ﹤0.01% | 6349 |
|
|
2023
Q1 | $229 | Buy |
147
+2
| +1% | +$3 | ﹤0.01% | 6417 |
|
|
2022
Q4 | $92 | Sell |
145
-1,154
| -89% | -$732 | ﹤0.01% | 6486 |
|
|
2022
Q3 | $2K | Sell |
1,299
-74
| -5% | -$114 | ﹤0.01% | 5852 |
|
|
2022
Q2 | $3K | Sell |
1,373
-17,145
| -93% | -$37.5K | ﹤0.01% | 5913 |
|
|
2022
Q1 | $114K | Sell |
18,518
-17,852
| -49% | -$110K | ﹤0.01% | 4941 |
|
|
2021
Q4 | $459K | Buy |
36,370
+26,476
| +268% | +$334K | ﹤0.01% | 4414 |
|
|
2021
Q3 | $907K | Sell |
9,894
-2,504
| -20% | -$230K | ﹤0.01% | 4072 |
|
|
2021
Q2 | $657K | Buy |
12,398
+583
| +5% | +$30.9K | ﹤0.01% | 4221 |
|
|
2021
Q1 | $425K | Sell |
11,815
-19,783
| -63% | -$712K | ﹤0.01% | 4475 |
|
|
2020
Q4 | $878K | Buy |
31,598
+16,089
| +104% | +$447K | ﹤0.01% | 4058 |
|
|
2020
Q3 | $776K | Sell |
15,509
-3,022
| -16% | -$151K | ﹤0.01% | 3953 |
|
|
2020
Q2 | $859K | Buy |
18,531
+2,666
| +17% | +$124K | ﹤0.01% | 3825 |
|
|
2020
Q1 | $724K | Buy |
15,865
+2,216
| +16% | +$101K | ﹤0.01% | 3657 |
|
|
2019
Q4 | $766K | Buy |
13,649
+5,529
| +68% | +$310K | ﹤0.01% | 3971 |
|
|
2019
Q3 | $203K | Buy |
8,120
+3,632
| +81% | +$90.8K | ﹤0.01% | 4774 |
|
|
2019
Q2 | $191K | Buy |
+4,488
| New | +$191K | ﹤0.01% | 4816 |
|